TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for Spyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | TANG CAPITAL MANAGEMENT, LLC | 1,892,200 2.400% | -1,307,800 (-40.87%) | Filing |
| 2025-05-01 4:15 pm Purchase | 2025-04-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | TANG CAPITAL MANAGEMENT, LLC | 3,200,000 5.300% | 3,200,000 (New Position) | Filing |